Surmodics: Q1 Earnings Insights - Surmodics (NASDAQ:SRDX)

Surmodics SRDX reported its Q1 earnings results on Thursday, February 3, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Surmodics beat estimated earnings by 58.06%, reporting an EPS of $-0.13 versus an estimate of $-0.31, which surprised analysts.

Revenue was up $706.00 thousand from the same period last year.

Last quarter the company beat on EPS by $0.15, which was followed by a 2.16% drop in the share price the next day.

Here's a look at Surmodics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.25	-0.17	0.63	-0.09
EPS Actual	-0.10	-0.17	0.62	0.02
Revenue Estimate	23.06M	23.31M	32.95M	22.37M
Revenue Actual	23.97M	23.87M	34.99M	22.30M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Surmodics management provided guidance for their next quarter, expecting earnings between $-1.75 and $-1.25 per share for the next quarter.

This represents a -1053.85% in quarter-over-quarter growth for Surmodics, a bearish signal to many investors.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.